Literature DB >> 22253067

Importance of normohydration for the long-term survival of haemodialysis patients.

Charles Chazot1, Peter Wabel, Paul Chamney, Ulrich Moissl, Sebastian Wieskotten, Volker Wizemann.   

Abstract

BACKGROUND: Fluid overload and hypertension are among the most important risk factors for haemodialysis (HD) patients. The aim of this study was to analyse the impact of fluid overload for the survival of HD patients by using a selected reference population from Tassin.
METHODS: A positively selected HD population (n = 50) from Tassin (Lyon-France) was used as a reference for fluid status and all-cause mortality. This population was compared to one dialysis centre from Giessen (Germany) which was separated into a non-hyperhydrated (n = 123) and a hyperhydrated (n = 35) patient group. The hydration status (ΔHS) of all patients was objectively measured with whole-body bioimpedance spectroscopy in 2003. All-cause mortality was analysed after a 6.5-year follow-up.
RESULTS: Most of the reference patients from Tassin were normohydrated (ΔHS = 0.25 ± 1.15 L) at the start of the HD session. The hydration status of the Tassin patients was not different to the non-hyperhydrated Giessen patients (ΔHS = 0.8 ± 1.1 L) but significantly lower than in the hyperhydrated Giessen group (ΔHS = 3.5 ± 1.2 L). Multivariate adjusted all-cause mortality was significantly increased in the hyperhydrated patient group (hazard ratio = 3.41)- no difference in mortality could be observed between the Tassin and the non-hyperhydrated group from Giessen-even considering the fact that Tassin patients presented a significantly lower blood pressure.
CONCLUSIONS: Fluid overload has a very high predictive value for all-cause mortality and seems to be one of the major killers in the HD population. Patients might strongly benefit from active management of fluid overload.

Entities:  

Mesh:

Year:  2012        PMID: 22253067     DOI: 10.1093/ndt/gfr678

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  66 in total

1.  Time to improve fluid management in hemodialysis: should we abandon clinical assessment and routinely use bioimpedance?

Authors:  Adrian Covic; Mihai Onofriescu
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-15       Impact factor: 8.237

2.  Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients.

Authors:  Charles Chazot; Margaux Rozes; Cyril Vo-Van; Patrik Deleaval; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Eric Zaoui; Guillaume Jean
Journal:  Cardiorenal Med       Date:  2017-04-29       Impact factor: 2.041

3.  Fluid management: the challenge of defining standards of care.

Authors:  Jennifer E Flythe; M Alan Brookhart
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

4.  Turning the Tide: Improving Fluid Management in Dialysis through Technology.

Authors:  Jennifer E Flythe
Journal:  J Am Soc Nephrol       Date:  2017-06-15       Impact factor: 10.121

5.  Chronic Fluid Overload and Mortality in ESRD.

Authors:  Carmine Zoccali; Ulrich Moissl; Charles Chazot; Francesca Mallamaci; Giovanni Tripepi; Otto Arkossy; Peter Wabel; Stefano Stuard
Journal:  J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 10.121

6.  Relative blood volume monitoring in hemodialysis patients: identifying its appropriate role.

Authors:  Peter Noel Van Buren
Journal:  Nephrol Dial Transplant       Date:  2019-08-01       Impact factor: 5.992

Review 7.  Peridialysis BP levels and risk of all-cause mortality: a dose-response meta-analysis.

Authors:  Yan Tu; Yu-Chen Han; Le-Ting Zhou; Ming-Ming Pan; Bin Wang; Hong Liu; Ri-Ning Tang; Bi-Cheng Liu
Journal:  J Hum Hypertens       Date:  2018-09-12       Impact factor: 3.012

8.  Dry weight assessment by combined ultrasound and bioimpedance monitoring in low cardiovascular risk hemodialysis patients: a randomized controlled trial.

Authors:  Dimitrie Siriopol; Mihai Onofriescu; Luminita Voroneanu; Mugurel Apetrii; Ionut Nistor; Simona Hogas; Mehmet Kanbay; Radu Sascau; Dragos Scripcariu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-12-07       Impact factor: 2.370

9.  Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes.

Authors:  Chen Huan-Sheng; Chang Yeong-Chang; Hsieh Ming-Hsing; Tseng Fan-Lieh; Lin Chu-Cheng; Wu Tsai-Kun; Chen Hung-Ping; Hung Sze-Hung; Chiu Hsien-Chang; Lee Chia-Chen; Hou Chun-Cheng; Cheng Chun-Ting; Liou Hung-Hsiang; Lin Chun-Ju; Lim Paik-Seong
Journal:  Int Urol Nephrol       Date:  2016-09-12       Impact factor: 2.370

10.  Bioimpedance spectroscopy method to determine hypervolemia in maintenance hemodialysis patients.

Authors:  O Merhametsiz; E G Oguz; O Yayar; B Bektan; B Canbakan; D Ayli
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.